rezafungin (Rezzayo)
Jump to navigation
Jump to search
Indications
- candidemia
- invasive candidiasis
Dosage
Adverse effects
More general terms
References
- ↑ Hein I FDA Panel Backs Weekly Rezafungin for Candidemia, Invasive Candidiasis. Efficacy, safety data sufficient to justify "limited use" indication, say panelists. MedPage Today January 25, 2023 https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/102799